- Home
- PYPD vs KITT Comparison
PYPD vs KITT Comparison
Compare PYPD & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- KITT
- Stock Information
- Founded
- PYPD 2008
- KITT 2014
- Country
- PYPD Israel
- KITT United States
- Employees
- PYPD N/A
- KITT N/A
- Industry
- PYPD Medical/Dental Instruments
- KITT Industrial Machinery/Components
- Sector
- PYPD Health Care
- KITT Industrials
- Exchange
- PYPD Nasdaq
- KITT Nasdaq
- Market Cap
- PYPD 34.8M
- KITT 37.7M
- IPO Year
- PYPD 2020
- KITT N/A
- Fundamental
- Price
- PYPD $3.19
- KITT $0.91
- Analyst Decision
- PYPD Strong Buy
- KITT
- Analyst Count
- PYPD 5
- KITT 0
- Target Price
- PYPD $11.40
- KITT N/A
- AVG Volume (30 Days)
- PYPD 114.4K
- KITT 1.8M
- Earning Date
- PYPD 08-13-2025
- KITT 08-19-2025
- Dividend Yield
- PYPD N/A
- KITT N/A
- EPS Growth
- PYPD N/A
- KITT N/A
- EPS
- PYPD N/A
- KITT N/A
- Revenue
- PYPD N/A
- KITT $1,508,374.00
- Revenue This Year
- PYPD N/A
- KITT $2,936.06
- Revenue Next Year
- PYPD N/A
- KITT N/A
- P/E Ratio
- PYPD N/A
- KITT N/A
- Revenue Growth
- PYPD N/A
- KITT N/A
- 52 Week Low
- PYPD $2.30
- KITT $0.82
- 52 Week High
- PYPD $3.93
- KITT $6.04
- Technical
- Relative Strength Index (RSI)
- PYPD 40.57
- KITT 44.22
- Support Level
- PYPD $3.07
- KITT $0.89
- Resistance Level
- PYPD $3.60
- KITT $1.00
- Average True Range (ATR)
- PYPD 0.18
- KITT 0.06
- MACD
- PYPD -0.05
- KITT -0.01
- Stochastic Oscillator
- PYPD 23.81
- KITT 9.65
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.